Limits of drug repurposing

A new study at Cambridge Judge Business School demonstrates how rare it is to find entirely new uses for existing medications

picture of

Breaking News

Eisai, BMS and H3 Biomedicine announce research collaboration

Bristol-Myers Squibb, Eisai and its US-based precision medicine research and development subsidiary H3 Biomedicine, ...

Bioscience sector shaping the future of new centre of excellence

Businesses are helping to shape the direction of a national centre of excellence for the bioscience industries, based ...

Only a handful of pharma companies are developing the urgently needed new medicines for the poor

The development of new medical products that are considered the highest priority for people in developing countries is ...

Commercial opportunities for emerging infectious diseases vaccine developers

Although development of interventions for emerging infectious diseases (EIDs) has traditionally been limited by a lack ...

Second failure of AstraZeneca’s Imfinzi + tremelimumab combination significant setback says GlobalData

Following the news (Friday 7 December) that the combination did not improve overall survival versus standard-of-care ...

Discover, learn and connect at Lab Innovations!

Experience the latest developments at the UK’s only event dedicated to the laboratory industry

WuXi AppTec expands site in California for pharmaceutical R&D services

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company ...

AC Immune and Lilly announce licence and collaboration agreement

Multi-year agreement focuses on Morphomer tau aggregation inhibitors, for the potential treatment of Alzheimer's ...

Plant-based expression systems expedite time to market

Leaf Expression Systems is a new contract development business specialising in the plant-based expression and ...

The nanozyme that uses light to kill bacteria

Scientists at the RMIT University in Australia have created a nanozyme with antimicrobial properties with huge ...

In vivo models to target respiratory diseases

Envigo’s Steve Jordan offers intuitive analysis and insights into methods of optimising in vivo efficacy studies and ...

BC Platforms and Medaffcon join forces to streamline collaboration between biobanks and researchers

BC Platforms AG, a world leader in genomic data management and analytics, today announces that it has partnered with ...

Quotient conducts translational pharmaceutics programme with Druggability Technologies

Quotient’s comprehensive drug product expertise spans all types of oral dosage forms, a broad range of solubilisation ...